'김갑성' 기자의 전체기사
-
MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Drive…
KARACHI, Pakistan, Dec. 23, 2025 -- MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat (KPSIAJ) announced the signing of a landmark Memorandum of Understanding (MOU) establishing a strategic collaboration to introduce responsible, community-centered AI innovation across KPSIAJ's education and healthcare ecosystem. Under this agreement, MindHYVE.ai™ will support KPSIAJ in deploying its proprietary agentic AI platforms, ArthurAI™ for adaptive learning and ChironAI™ for clinical decision-support readiness evaluations, across the Fatimiyah Education Network (FEN), Fatimi
- 김갑성 기자
- 2025-12-23 07:30
-
Temu Signs Australian Equipment Safety Pledge to Enhance…
SYDNEY, Dec. 23, 2025 -- Temu has joined the Australian Communications and Media Authority (ACMA)'s Equipment Safety Pledge, a new voluntary initiative aimed at strengthening consumer protections and reduce the availability of unsafe or illegal communications devices sold online. Temu is among the founding signatories of the pledge, alongside other major e-commerce platforms, reflecting a shared commitment to consumer safety and regulatory compliance in Australia. Announced by the ACMA in December 2025, the pledge outlines a series of voluntary commitments aimed at helping prevent the
- 김갑성 기자
- 2025-12-23 07:00
-
TraceLink Wins 2025 Merit Award -- Recognized for Healthcare…
TraceLink has been named a winner of the 2025 Merit Awards for Healthcare Innovation, marking its third consecutive year of recognition. The award honors TraceLink's continued leadership in transforming the life sciences and healthcare supply chain through OPUS—its industrial no-code platform that powers agentic supply chain orchestration across a global network of more than 310,000 authenticated partners. BOSTON, Dec. 22, 2025 -- TraceLink, the world's largest end-to-end digital network platform for intelligent supply chain orchestration, today announced that it has been named
- 김갑성 기자
- 2025-12-22 23:00
-
MCB Group Unveils Daily Sports Nutrition Innovations at SupplyS…
TAIPEI, Dec. 22, 2025 -- MCB Group, a Taiwan-based global manufacturer of premium nutritional powder ingredients, has further streamlined its operations into a full CDMO private-label provider, showcasing a range of trend-driven branded ingredients and turnkey total solutions at SupplySide Global 2025, aimed at capturing growth in next year's booming market. The focus on MCB's new ingredients reflects insights generated through its AI-powered market platform, revealing a clear shift: sports nutrition is rapidly becoming part of everyday nutrition. Consumers now prefer convenien
- 김갑성 기자
- 2025-12-22 22:00
-
AI Platform to Combat Muscle Loss and Preserve Metabolic Vit…
Livelively USA combines AI insights with Eastern wellness principles to support healthier long-term weight management behaviors. NEW YORK, Dec. 22, 2025 -- Weight-loss medications are reshaping global healthcare, with the anti-obesity drug market projected to approach $100 billion by 2030, according to Goldman Sachs. As millions begin GLP-1 therapy, interest is growing around how to maintain strength, vitality, and well-being throughout treatment. Livelively USA Inc. today introduced a metabolic wellness platform that integrates predictive AI with Integrative Longevity S
- 김갑성 기자
- 2025-12-22 21:00
-
Yii Partners with Japan's ANDS Corporation: Building Skin Resili…
HONG KONG, Dec. 22, 2025 -- Japanese skincare brand Yii is collaborating with ANDS Corporation (hereinafter "ANDS"), an affiliate of Rohto Pharmaceutical Co., Ltd., to explore the niche skincare market with pharmaceutical-grade scientific excellence. The collaboration combines over 60 years of ANDS's formulation expertise with Yii's Eastern philosophy of "Nourish effortless beauty," delivering proven efficacy and high safety for sensitive, barrier-compromised, and early-aging skin types. Where Eastern Philosophy Meets Japanese Craftsmanship Modern lifestyles,
- 김갑성 기자
- 2025-12-22 17:51
-
Menarini Silicon Biosystems announces PACE trial biomarker…
The secondary analysis of the PACE trial highlights the value of counting Circulating Tumor Cells (CTCs) in the blood to help guide treatment escalation or de-escalation in patients with hormone receptor-positive (HR+), HER2-negative (HER2-) metastatic breast cancer whose disease progressed after treatment with aromatase inhibitors plus CDK4/6 inhibitors. CTC count is a standalone predictive biomarker, independent of clinical risk factors and circulating tumor DNA. BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 22, 2025 -- Menarini Silicon Biosystems, a pioneer of cell-based l
- 김갑성 기자
- 2025-12-22 16:00
-
Guardant Health Japan receives regulatory approval of Gua…
[ 메디채널 김갑성 기자 ] Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer for treatment with imlunestrant TOKYO, Dec. 22, 2025 -- Guardant Health Japan Corp. today announced that the Ministry of Health, Labour and Welfare (MHLW) has approved Guardant360® CDx on 23 October 2025 as a companion diagnostic to identify ESR1 mutations in patients with hormone receptor–positive, HER2-negative breast cancer with disease progression following endocrine therapy, for consi
- 김갑성 기자
- 2025-12-22 16:00
-
산야에서 제8회 하이난 국제 건강산업 박람회 개막
[ 메디채널 김갑성 기자 ] 하이커우, 중국 2025년 12월 22일 -- 하이난 국제 미디어 센터 보도자료: 2025년 12월 20일 산야에서 제8회 하이난 국제 건강산업 박람회(Hainan International Health Industry)가 개최되었다. 하이난 자유무역항(Free Trade Port, FTP)에 독립적인 특별 통관 제도가 공식적으로 시행되는 중요한 시기와 맞물려 열린 박람회는 하이난이 건강 산업 발전상을 알리는 무대이자 건강 산업의 미래를 가늠할 수 있는 일종의 전망대 구실을 한다. 1만 2천 제곱미터 면적에서 나흘간 진행되는 올해의 박람회에는 253개의 국내외 기업이 참여하여 혁신적인 의약품, 의료 기기, 스마트 헬스케어, 재활 및 노인 요양, 전통 중의학, 고성능 건강 관리 제품을 출품했다. 세계 각국의 최첨단 기술, 제품, 서비스 방식을 전시하는 특별 국제 전시 구역(International Exhibition Area)도 별도로 마련되었다. 인공지능(AI) 보조 진단 시스템, 원격 의료 플랫폼, 최소 침습 수술 장비가 행사장을 방문한 건강 산업 전문가들의 큰 관심을 끌고 있다. 한편,
- 김갑성 기자
- 2025-12-22 14:12
-
ZeroAvia Completes Financing Round
KEMBLE, UK and EVERETT, Wash., Dec. 22, 2025 -- ZeroAvia today announced that it has completed a further round of financing, led by Barclays Climate Ventures, Breakthrough Energy Ventures, Ecosystem Integrity Fund, Horizons Ventures, Summa Equity, and AP Ventures, with participation from the National Wealth Fund and the Scottish National Investment Bank. With additional investment secured, ZeroAvia has extended its cash runway for the next two years and will continue to fully industrialize its hydrogen power and propulsion technology for the aviation and defense markets.
- 김갑성 기자
- 2025-12-22 13:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 5하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 6대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 7만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2026-01-31_SAT
- CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK 12:05
- Origin Agritech Announces Fiscal Year 2025 Results 06:00
- White Pearl Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering 05:47
- Planet Green Holdings Corp. Provides Response to Unusual Market Action 05:05
- SKF completes previously announced divestment of non-core aerospace operation in Elgin, USA 03:36
- DOCOMO Concludes Partnership Agreement with Aduna to Advance Global Network API Expansion 03:34
- Photo Dance: Making AI Dance Trends Accessible to Everyone - How This App Lets Ordinary Users Join the Dance Wave Without Appearing On Camera 00:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2026년 01월 31일 13시 40분